Skip to main content
Caplight Logo









Linneo Health

Linneo Health

Private
MadridHealthcare & Life Scienceshttps://linneohealth.com/

Last Round

Corporate Funding

Nov 1, 2024

Total Funding Raised

$25.37M

Company Overview

Linneo Health is a pharmaceutical company that specializes in the research, cultivation, and supply of medicinal cannabis flowers, extracts, and products for pharmaceutical partners.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

medicinal cannabisactive pharmaceutical ingredientsAPIcannabis cultivationEU-GMP certifiedpharma supply chaincontract manufacturingCMOcannabis extractsmedical marijuanapharmaceutical raw materialscannabis researchB2B pharmacannabis processing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Linneo Health Comparables

Compare Linneo Health with similar companies based on industry and business-model similarity.

Linneo Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Brains Bioceutical Corp
88%
Symtomax
83%
Bedrocan
81%

Linneo Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingNov 1, 2024
Corporate FundingJun 1, 2024
Corporate FundingJan 1, 2019
Corporate FundingSep 1, 2018

Key People

Founding team and executive leadership

Don Bellamy

Chief Executive Officer

Executive Team

Gerardo Gorostiza

CFO - Chief Financial and Strategy Officer

Executive Team

Linneo Health Investors

Notable investors and investment history

Linneo Health investors
InvestorRounds
GHO CapitalCorporate Funding
TorrealCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors increased 87% MoM.

  • Nov 13, 2025

    Monthly visitors grew 204% MoM, reaching 2.9K.

Linneo Health Filings

Explore SEC and related filing metadata, where available.

Linneo Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Linneo Health's valuation, stock price, and market status.

Is Linneo Health a public or private company?

Linneo Health is a private company.

What is the current stock price of Linneo Health?

Linneo Health is a private company with no public stock price. No recent secondary market data is available.

How much is Linneo Health worth (valuation)?

Valuation information for Linneo Health is not publicly available.

Can I buy Linneo Health stock?

Linneo Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Linneo Health's last funding round?

Linneo Health's most recent funding round was Corporate Funding on November 1, 2024.

Who are the main investors in Linneo Health?

Key investors in Linneo Health include GHO Capital, Torreal.

Will Linneo Health IPO soon?

No public IPO plans have been announced for Linneo Health.

How can I track Linneo Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Linneo Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMadrid
Employee Range69
Year Founded2018
Last FundingNov 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?